Social Norms Intervention for the prevention of Polydrug usE

Social Norms Intervention for the prevention of Polydrug usE - SNIPE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004375

Enrollment

14000

Registered

2012-10-09

Start date

2012-01-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Consumption of licit and illicit drugs

Interventions

Group 1: Intervention group: Attitudes toward and rates of legal and illegal drug use will be assessed at baseline. The intervention group will receive individualized social norms feedback. The websit

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Enrollment at participating universities

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Attitudes toward personal and peer drug use: Personal and perceived social norms regarding attitudes towards substance use will also be assessed. These items will again be based on existing research and will be tailored to the target population of students. The response options range from ‘Never ok to use’ to ‘Ok to use frequently if that is what the person wants to do‘. Data will be assessed at baseline and 5 months later using an internt-based questionnaire.	—

Measure

Time frame

Attitudes toward personal and peer drug use: Personal and perceived social norms regarding attitudes towards substance use will also be assessed. These items will again be based on existing research and will be tailored to the target population of students. The response options range from ‘Never ok to use’ to ‘Ok to use frequently if that is what the person wants to do‘. Data will be assessed at baseline and 5 months later using an internt-based questionnaire.

—

Secondary

Measure	Time frame
Drug use: The use of the following drugs will be assessed: Alcoholic beverages (beer, wine, spirits, etc.), tobacco products (cigarettes, chewing tobacco, cigars, etc.), cannabis (marijuana, pot, grass, hash, etc.), medication to improve academic performance (e.g. Ritalin) which was not prescribed, synthetic cannabis (spice, etc.), cocaine (coke, crack, etc.), ecstasy, other amphetamine-type stimulants (speed, meth, etc.), sedatives or sleeping pills (diazepam, alprazolam, flunitrazepam, midazolam, stilnoct, etc.) which were not prescribed, hallucinogens (LSD, acid, mushrooms, trips, ketamine, etc.), inhalants (nitrous, glue, petrol, paint thinner, etc.). In addition, binge drinking and polydrug use (alcohol and tobacco, alcohol and any other illicit drug) will be assessed. The choice of drugs included will be based on the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), developed by the World Health Organisation. Data will be assessed at baseline and 5 months later using an internt-based questionnaire.	—

Measure

Time frame

Drug use: The use of the following drugs will be assessed: Alcoholic beverages (beer, wine, spirits, etc.), tobacco products (cigarettes, chewing tobacco, cigars, etc.), cannabis (marijuana, pot, grass, hash, etc.), medication to improve academic performance (e.g. Ritalin) which was not prescribed, synthetic cannabis (spice, etc.), cocaine (coke, crack, etc.), ecstasy, other amphetamine-type stimulants (speed, meth, etc.), sedatives or sleeping pills (diazepam, alprazolam, flunitrazepam, midazolam, stilnoct, etc.) which were not prescribed, hallucinogens (LSD, acid, mushrooms, trips, ketamine, etc.), inhalants (nitrous, glue, petrol, paint thinner, etc.). In addition, binge drinking and polydrug use (alcohol and tobacco, alcohol and any other illicit drug) will be assessed. The choice of drugs included will be based on the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), developed by the World Health Organisation. Data will be assessed at baseline and 5 months later using an internt-based questionnaire.

—

Countries

Belgium, Denmark, Germany, Slovakia, Spain, Turkey, United Kingdom

Contacts

Public ContactStefanie Helmer

BIPS - Institut für Epidemiologie und Präventionsforschung GmbH

helmer@bips.uni-bremen.de0049 421 218 56909

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 25, 2026